Text Size
225 studies found for:    treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression
Condition: Human Immunodeficiency Virus
Interventions: Drug: Atazanavir, ritonavir, lamivudine;   Drug: Atazanavir, Ritonavir, 2 NRTIs
22 Recruiting Examining Factors That May Influence Resistance to HIV-1 Infection
Condition: HIV Infections
Intervention:
23 Recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
24 Unknown † Pediatric Nevirapine Resistance Study
Conditions: AIDS;   HIV Infections
Intervention: Drug: nevirapine
25 Unknown † Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
26 Recruiting A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Second line ART regimens are usually based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs);   Drug: Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & available;   Other: SOC adherence versus SOC+CPI adherence
27 Not yet recruiting Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings
Condition: HIV
Interventions: Other: EMR Only;   Other: EMR+CDSS
28 Recruiting Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV-Infected Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Raltegravir (MK-0518)
29 Recruiting The VMVN Study: Virological Monitoring in Viet Nam
Conditions: HIV Infection;   AIDS
Interventions: Other: Standard Care;   Other: Virological Monitoring
30 Recruiting National Evaluation of PI-based 2nd Line Efficacy in Cambodia
Condition: HIV
Intervention:
31 Available Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
32 Recruiting A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus
Intervention: Drug: sofosbuvir + Ribavirin (RBV)
33 Not yet recruiting Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
34 Recruiting Kumasi Cohort Study
Condition: HIV
Intervention: Other: Virological monitoring
35 Recruiting Study of Options for Second-Line Effective Combination Therapy (SELECT)
Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Abacavir/lamivudine/zidovudine;   Drug: Abacavir/lamivudine;   Drug: Lamivudine/zidovudine;   Drug: Abacavir;   Drug: Zidovudine;   Drug: Lamivudine
36 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
37 Unknown † Resistance to HIV Infection
Condition: HIV Infections
Intervention:
38 Not yet recruiting Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
Conditions: HIV Related Insulin Resistance;   Protease Inhibitor Related Insulin Resistance;   Endoplasmic Reticulum Stress
Intervention: Drug: Tauroursodeoxycholic acid
39 Recruiting Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
40 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years